SYNTHETIC MULTIEPITOPIC CHIMERA AS VACCINE AND TREATMENT AGAINST LEISHMANIOSIS IN MAMMALS (Machine-translation by Google Translate, not legally binding)

Synthetic multiepitopic chimera as a vaccine and treatment against leishmaniasis in mammals. The invention relates to synthetic chimeras including 4 multiepitopic peptides against Leishmania. Each of the peptides has been selected from a Leishmania infantum protein. These are the nucleosomal histone...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CARRION HERRERO, FRANCISCO JAVIER, DOMINGUEZ BERNAL, GUSTAVO, MAS ZUBIRI, ALICIA, DE LA FUENTE LOPEZ, RICARDO, MARTINEZ RODRIGO, ABEL, ORDEN GUTIERREZ, JOSE ANTONIO
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CARRION HERRERO, FRANCISCO JAVIER
DOMINGUEZ BERNAL, GUSTAVO
MAS ZUBIRI, ALICIA
DE LA FUENTE LOPEZ, RICARDO
MARTINEZ RODRIGO, ABEL
ORDEN GUTIERREZ, JOSE ANTONIO
description Synthetic multiepitopic chimera as a vaccine and treatment against leishmaniasis in mammals. The invention relates to synthetic chimeras including 4 multiepitopic peptides against Leishmania. Each of the peptides has been selected from a Leishmania infantum protein. These are the nucleosomal histones H2A, H2B, H3 and H4. The invention also relates to a pharmaceutical composition that includes one of these synthetic chimeras. It also refers to a prophylactic and/or therapeutic vaccine against Leishmania spp for use in mammals and especially in humans and dogs. (Machine-translation by Google Translate, not legally binding) Quimera sintética multiepitópica como vacuna y tratamiento frente a leishmaniosis en mamíferos. La invención se refiere a quimeras sintéticas que incluyen 4 péptidos multiepitópicos frente a Leishmania. Cada uno de los péptidos se ha seleccionado de una proteína de Leishmania infantum. Se trata de las histonas nucleosomales H2A, H2B, H3 y H4. La invención también se refiere a una composición farmacéutica que incluye una de estas quimeras sintéticas. También se refiere a una vacuna profiláctica y/o terapéutica frente a Leishmania spp para su uso en mamíferos y, especialmente, en humana y en perros.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2795149A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2795149A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2795149A13</originalsourceid><addsrcrecordid>eNqNis1KA0EQBvfiQdR3-I4K5hB_kBybsc027ExCphU8hUls14VhJrh7yZv4uHrIA3gqqqjz5ie-B21ZxcG_diq8Fl2t_8y14nlDoIg3ck4Cg8IzdMOknoOCliQhKjqW2HoKsooSIQGevKcu4tqn_ddQbDZ9pzLmNA21YHfEstY-G_RU7RalTsjWp5yP2A3lYyj9zWVz9pnyaFcnXjR4YXXtzA51a-Mh7a3YtOV497R4nD8saH7_j-UXxdlIjw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SYNTHETIC MULTIEPITOPIC CHIMERA AS VACCINE AND TREATMENT AGAINST LEISHMANIOSIS IN MAMMALS (Machine-translation by Google Translate, not legally binding)</title><source>esp@cenet</source><creator>CARRION HERRERO, FRANCISCO JAVIER ; DOMINGUEZ BERNAL, GUSTAVO ; MAS ZUBIRI, ALICIA ; DE LA FUENTE LOPEZ, RICARDO ; MARTINEZ RODRIGO, ABEL ; ORDEN GUTIERREZ, JOSE ANTONIO</creator><creatorcontrib>CARRION HERRERO, FRANCISCO JAVIER ; DOMINGUEZ BERNAL, GUSTAVO ; MAS ZUBIRI, ALICIA ; DE LA FUENTE LOPEZ, RICARDO ; MARTINEZ RODRIGO, ABEL ; ORDEN GUTIERREZ, JOSE ANTONIO</creatorcontrib><description>Synthetic multiepitopic chimera as a vaccine and treatment against leishmaniasis in mammals. The invention relates to synthetic chimeras including 4 multiepitopic peptides against Leishmania. Each of the peptides has been selected from a Leishmania infantum protein. These are the nucleosomal histones H2A, H2B, H3 and H4. The invention also relates to a pharmaceutical composition that includes one of these synthetic chimeras. It also refers to a prophylactic and/or therapeutic vaccine against Leishmania spp for use in mammals and especially in humans and dogs. (Machine-translation by Google Translate, not legally binding) Quimera sintética multiepitópica como vacuna y tratamiento frente a leishmaniosis en mamíferos. La invención se refiere a quimeras sintéticas que incluyen 4 péptidos multiepitópicos frente a Leishmania. Cada uno de los péptidos se ha seleccionado de una proteína de Leishmania infantum. Se trata de las histonas nucleosomales H2A, H2B, H3 y H4. La invención también se refiere a una composición farmacéutica que incluye una de estas quimeras sintéticas. También se refiere a una vacuna profiláctica y/o terapéutica frente a Leishmania spp para su uso en mamíferos y, especialmente, en humana y en perros.</description><language>eng ; spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201120&amp;DB=EPODOC&amp;CC=ES&amp;NR=2795149A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201120&amp;DB=EPODOC&amp;CC=ES&amp;NR=2795149A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CARRION HERRERO, FRANCISCO JAVIER</creatorcontrib><creatorcontrib>DOMINGUEZ BERNAL, GUSTAVO</creatorcontrib><creatorcontrib>MAS ZUBIRI, ALICIA</creatorcontrib><creatorcontrib>DE LA FUENTE LOPEZ, RICARDO</creatorcontrib><creatorcontrib>MARTINEZ RODRIGO, ABEL</creatorcontrib><creatorcontrib>ORDEN GUTIERREZ, JOSE ANTONIO</creatorcontrib><title>SYNTHETIC MULTIEPITOPIC CHIMERA AS VACCINE AND TREATMENT AGAINST LEISHMANIOSIS IN MAMMALS (Machine-translation by Google Translate, not legally binding)</title><description>Synthetic multiepitopic chimera as a vaccine and treatment against leishmaniasis in mammals. The invention relates to synthetic chimeras including 4 multiepitopic peptides against Leishmania. Each of the peptides has been selected from a Leishmania infantum protein. These are the nucleosomal histones H2A, H2B, H3 and H4. The invention also relates to a pharmaceutical composition that includes one of these synthetic chimeras. It also refers to a prophylactic and/or therapeutic vaccine against Leishmania spp for use in mammals and especially in humans and dogs. (Machine-translation by Google Translate, not legally binding) Quimera sintética multiepitópica como vacuna y tratamiento frente a leishmaniosis en mamíferos. La invención se refiere a quimeras sintéticas que incluyen 4 péptidos multiepitópicos frente a Leishmania. Cada uno de los péptidos se ha seleccionado de una proteína de Leishmania infantum. Se trata de las histonas nucleosomales H2A, H2B, H3 y H4. La invención también se refiere a una composición farmacéutica que incluye una de estas quimeras sintéticas. También se refiere a una vacuna profiláctica y/o terapéutica frente a Leishmania spp para su uso en mamíferos y, especialmente, en humana y en perros.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNis1KA0EQBvfiQdR3-I4K5hB_kBybsc027ExCphU8hUls14VhJrh7yZv4uHrIA3gqqqjz5ie-B21ZxcG_diq8Fl2t_8y14nlDoIg3ck4Cg8IzdMOknoOCliQhKjqW2HoKsooSIQGevKcu4tqn_ddQbDZ9pzLmNA21YHfEstY-G_RU7RalTsjWp5yP2A3lYyj9zWVz9pnyaFcnXjR4YXXtzA51a-Mh7a3YtOV497R4nD8saH7_j-UXxdlIjw</recordid><startdate>20201120</startdate><enddate>20201120</enddate><creator>CARRION HERRERO, FRANCISCO JAVIER</creator><creator>DOMINGUEZ BERNAL, GUSTAVO</creator><creator>MAS ZUBIRI, ALICIA</creator><creator>DE LA FUENTE LOPEZ, RICARDO</creator><creator>MARTINEZ RODRIGO, ABEL</creator><creator>ORDEN GUTIERREZ, JOSE ANTONIO</creator><scope>EVB</scope></search><sort><creationdate>20201120</creationdate><title>SYNTHETIC MULTIEPITOPIC CHIMERA AS VACCINE AND TREATMENT AGAINST LEISHMANIOSIS IN MAMMALS (Machine-translation by Google Translate, not legally binding)</title><author>CARRION HERRERO, FRANCISCO JAVIER ; DOMINGUEZ BERNAL, GUSTAVO ; MAS ZUBIRI, ALICIA ; DE LA FUENTE LOPEZ, RICARDO ; MARTINEZ RODRIGO, ABEL ; ORDEN GUTIERREZ, JOSE ANTONIO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2795149A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>CARRION HERRERO, FRANCISCO JAVIER</creatorcontrib><creatorcontrib>DOMINGUEZ BERNAL, GUSTAVO</creatorcontrib><creatorcontrib>MAS ZUBIRI, ALICIA</creatorcontrib><creatorcontrib>DE LA FUENTE LOPEZ, RICARDO</creatorcontrib><creatorcontrib>MARTINEZ RODRIGO, ABEL</creatorcontrib><creatorcontrib>ORDEN GUTIERREZ, JOSE ANTONIO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CARRION HERRERO, FRANCISCO JAVIER</au><au>DOMINGUEZ BERNAL, GUSTAVO</au><au>MAS ZUBIRI, ALICIA</au><au>DE LA FUENTE LOPEZ, RICARDO</au><au>MARTINEZ RODRIGO, ABEL</au><au>ORDEN GUTIERREZ, JOSE ANTONIO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SYNTHETIC MULTIEPITOPIC CHIMERA AS VACCINE AND TREATMENT AGAINST LEISHMANIOSIS IN MAMMALS (Machine-translation by Google Translate, not legally binding)</title><date>2020-11-20</date><risdate>2020</risdate><abstract>Synthetic multiepitopic chimera as a vaccine and treatment against leishmaniasis in mammals. The invention relates to synthetic chimeras including 4 multiepitopic peptides against Leishmania. Each of the peptides has been selected from a Leishmania infantum protein. These are the nucleosomal histones H2A, H2B, H3 and H4. The invention also relates to a pharmaceutical composition that includes one of these synthetic chimeras. It also refers to a prophylactic and/or therapeutic vaccine against Leishmania spp for use in mammals and especially in humans and dogs. (Machine-translation by Google Translate, not legally binding) Quimera sintética multiepitópica como vacuna y tratamiento frente a leishmaniosis en mamíferos. La invención se refiere a quimeras sintéticas que incluyen 4 péptidos multiepitópicos frente a Leishmania. Cada uno de los péptidos se ha seleccionado de una proteína de Leishmania infantum. Se trata de las histonas nucleosomales H2A, H2B, H3 y H4. La invención también se refiere a una composición farmacéutica que incluye una de estas quimeras sintéticas. También se refiere a una vacuna profiláctica y/o terapéutica frente a Leishmania spp para su uso en mamíferos y, especialmente, en humana y en perros.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_ES2795149A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title SYNTHETIC MULTIEPITOPIC CHIMERA AS VACCINE AND TREATMENT AGAINST LEISHMANIOSIS IN MAMMALS (Machine-translation by Google Translate, not legally binding)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A17%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CARRION%20HERRERO,%20FRANCISCO%20JAVIER&rft.date=2020-11-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2795149A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true